Emerging Competitors
| EWPI Stock | USD 0.0001 0.00 0.000003% |
Emerging World vs Alpha Wastewater Correlation
No risk reduction
The correlation between Emerging World Pharma and AWWI is 1.0 (i.e., No risk reduction) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Emerging World Pharma and AWWI in the same portfolio, assuming nothing else is changed.
Emerging World Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Emerging World and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Emerging and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Emerging World Pharma does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Emerging Stock performing well and Emerging World Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Emerging World's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BCAP | 11.82 | 3.67 | 0.00 | (0.73) | 0.00 | 0.00 | 250.00 | |||
| ALDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| HALL | 1.47 | 0.67 | 0.00 | (2.00) | 0.00 | 4.90 | 14.75 | |||
| IKTO | 11.89 | 3.22 | 0.00 | 0.60 | 0.00 | 0.00 | 266.67 | |||
| LNTO | 10.18 | 0.12 | 0.00 | (0.02) | 14.84 | 22.61 | 101.51 | |||
| OHCS | 1.49 | (0.69) | 0.00 | 0.84 | 0.00 | 0.00 | 50.00 | |||
| ECDD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| VNTN | 1.49 | (0.80) | 0.00 | (2.18) | 0.00 | 0.00 | 50.00 | |||
| KCMH | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| AWWI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cross Equities Net Income Analysis
Compare Emerging World Pharma and related stocks such as Baron Capital, Atlantica, and Hallmark Financial Net Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VNTN | (2 K) | (137.8 K) | (137.8 K) | (137.8 K) | (137.8 K) | (137.8 K) | (137.8 K) | (137.8 K) | (137.8 K) | (137.8 K) | (137.8 K) | (137.8 K) | (137.8 K) | (137.8 K) | (137.8 K) | (124 K) | (117.8 K) |
Emerging World Pharma and related stocks such as Baron Capital, Atlantica, and Hallmark Financial Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Emerging World Pharma financial statement analysis. It represents the amount of money remaining after all of Emerging World Pharma operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Emerging World Competitive Analysis
The better you understand Emerging World competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Emerging World's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Emerging World's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Emerging World Competition Performance Charts
Five steps to successful analysis of Emerging World Competition
Emerging World's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Emerging World Pharma in relation to its competition. Emerging World's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Emerging World in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Emerging World's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Emerging World Pharma, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Emerging World position
In addition to having Emerging World in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Target Outcome ETFs Thematic Idea Now
Target Outcome ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Outcome ETFs theme has 86 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Outcome ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Emerging World Correlation with its peers. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is there potential for Drug Manufacturers - Specialty & Generic market expansion? Will Emerging introduce new products? Factors like these will boost the valuation of Emerging World. Projected growth potential of Emerging fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Emerging World listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0) |
The market value of Emerging World Pharma is measured differently than its book value, which is the value of Emerging that is recorded on the company's balance sheet. Investors also form their own opinion of Emerging World's value that differs from its market value or its book value, called intrinsic value, which is Emerging World's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Emerging World's market value can be influenced by many factors that don't directly affect Emerging World's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Emerging World's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Emerging World should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Emerging World's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.